191 related articles for article (PubMed ID: 18209523)
1. Perineural injection of etanercept as a treatment for postamputation pain.
Dahl E; Cohen SP
Clin J Pain; 2008 Feb; 24(2):172-5. PubMed ID: 18209523
[TBL] [Abstract][Full Text] [Related]
2. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
[TBL] [Abstract][Full Text] [Related]
3. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.
Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF
Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E; Davoodifar S
Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica.
Cohen SP; Bogduk N; Dragovich A; Buckenmaier CC; Griffith S; Kurihara C; Raymond J; Richter PJ; Williams N; Yaksh TL
Anesthesiology; 2009 May; 110(5):1116-26. PubMed ID: 19387178
[TBL] [Abstract][Full Text] [Related]
6. Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice.
Dogrul A; Gul H; Yesilyurt O; Ulas UH; Yildiz O
Acta Diabetol; 2011 Jun; 48(2):135-42. PubMed ID: 21104419
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and treatment issues in postamputation pain after landmine injury.
Wiffen P; Meynadier J; Dubois M; Thurel C; deSmet J; Harden RN
Pain Med; 2006; 7 Suppl 2():S209-12. PubMed ID: 17112354
[No Abstract] [Full Text] [Related]
8. Parapharyngeal abscess in a patient receiving etanercept.
Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
[TBL] [Abstract][Full Text] [Related]
9. Painful and nonpainful phantom and stump sensations in acute traumatic amputees.
Schley MT; Wilms P; Toepfner S; Schaller HP; Schmelz M; Konrad CJ; Birbaumer N
J Trauma; 2008 Oct; 65(4):858-64. PubMed ID: 18849803
[TBL] [Abstract][Full Text] [Related]
10. Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation.
Boettger MK; Weber K; Grossmann D; Gajda M; Bauer R; Bär KJ; Schulz S; Voss A; Geis C; Bräuer R; Schaible HG
Arthritis Rheum; 2010 May; 62(5):1308-18. PubMed ID: 20213802
[TBL] [Abstract][Full Text] [Related]
11. Training with virtual visual feedback to alleviate phantom limb pain.
Mercier C; Sirigu A
Neurorehabil Neural Repair; 2009; 23(6):587-94. PubMed ID: 19171946
[TBL] [Abstract][Full Text] [Related]
12. Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
Moutsopoulos NM; Katsifis GE; Angelov N; Leakan RA; Sankar V; Pillemer S; Wahl SM
Ann Rheum Dis; 2008 Oct; 67(10):1437-43. PubMed ID: 18198195
[TBL] [Abstract][Full Text] [Related]
13. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
[TBL] [Abstract][Full Text] [Related]
16. Perispinal etanercept for neuroinflammatory disorders.
Tobinick E
Drug Discov Today; 2009 Feb; 14(3-4):168-77. PubMed ID: 19027875
[TBL] [Abstract][Full Text] [Related]
17. Recalcitrant hand pompholyx: variable response to etanercept.
Ogden S; Clayton TH; Goodfield MJ
Clin Exp Dermatol; 2006 Jan; 31(1):145-6. PubMed ID: 16309517
[No Abstract] [Full Text] [Related]
18. Dissociation of phantom limb phenomena from stump tactile spatial acuity and sensory thresholds.
Hunter JP; Katz J; Davis KD
Brain; 2005 Feb; 128(Pt 2):308-20. PubMed ID: 15634736
[TBL] [Abstract][Full Text] [Related]
19. Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats.
Norimoto M; Ohtori S; Yamashita M; Inoue G; Yamauchi K; Koshi T; Suzuki M; Orita S; Eguchi Y; Sugiura A; Ochiai N; Takaso M; Takahashi K
Spine (Phila Pa 1976); 2008 Oct; 33(22):2403-8. PubMed ID: 18824950
[TBL] [Abstract][Full Text] [Related]
20. Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.
Cavazzana I; Ceribelli A; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):104-6. PubMed ID: 19014870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
